Covista Inc. CVSA R2K
Company Overview
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Why Investors Should Care
Generates a return on equity of 17.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 15.2%.
Trades at a P/E of 17.0, below the sector median of 20.6.
Operating margin of 18.9% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jun 2025 Revenue of $1.79B (+12.9% YoY); net profit $237.06M.
- Trailing 12 Months Year-on-year growth — revenue +4.5%, earnings -24.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.3%, profit CAGR 2.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.27% |
| 1 Year: | 4.50% |
Compounded Profit Growth
| 5 Years: | 2.27% |
| 1 Year: | -24.60% |
Stock Price Performance
| 1 Year: | -2.48% |
| 6 Months: | -0.20% |
| 3 Months: | +1.98% |
| 1 Month: | -9.80% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)37.38 · Neutral
P/E of 16.98 is below the sector median of 20.61 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 25.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CVSA Covista Inc. R2K | 115.82 | 16.98 | $3.94B | 0.00% | 15.22% | 17.85% | 1.27% | 2.27% |
| 2 | WMT Walmart Inc. SPX | 112.53 | 39.62 | $895.52B | 0.89% | 18.21% | 24.13% | 5.27% | 23.30% |
| 3 | COST Costco Wholesale Corporation NDXSPX | 916.54 | 46.24 | $406.47B | 0.63% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPX | 82.45 | 25.93 | $354.74B | 2.52% | 16.47% | 43.37% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPX | 148.05 | 21.64 | $344.75B | 2.92% | 22.93% | 31.11% | 0.36% | 1.66% |
| 6 | PM Philip Morris International Inc. SPX | 180.88 | 25.44 | $281.91B | 3.34% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPX | 135.40 | 17.75 | $184.96B | 4.37% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | MO Altria Group, Inc. SPX | 70.52 | 14.72 | $117.76B | 6.04% | 38.27% | - | 1.24% | -1.89% |
| 9 | MNST Monster Beverage Corporation NDXSPX | 97.57 | 47.14 | $95.42B | 0.00% | 28.33% | 26.65% | 13.03% | 14.82% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 292.04M | 301.51M | 299.14M | 315.22M | 293.14M | 308.21M | 310.07M | 319.79M | 236.94M | 253.96M | 258.70M | 264.24M | 254.61M | 266.17M | 271.49M | 259.73M | 218.83M | 234.40M | 230.21M | 223.47M | 289.07M | 371.20M | 364.28M | 361.23M | 354.27M | 362.83M | 369.08M | 368.85M | 393.24M | 412.66M | 417.40M | 447.73M | 466.06M | 462.29M | 503.38M | 487.03M |
| Operating Income | 8.25M | -56.38M | 60.85M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.95M | 29.06M | 35.96M | 27.08M | -22.06M | 24.73M | 32.95M | 44.53M | 23.63M | 45.55M | 59.43M | 28.19M | 58.61M | 61.73M | 70.24M | 103.87M | 90.51M | 85.48M | 111.11M | 91.34M |
| Net Income | 5.46M | -50.59M | 51.92M | -9.97M | 25.15M | 14.41M | 39.86M | 42.86M | 12.79M | -81.16M | 39.33M | 62.81M | -9.53M | 17.30M | 37.91M | 49.50M | 14.36M | 5.53M | 150.83M | -256.05M | 19.93M | 23.32M | 24.65M | 9.01M | -58.00M | 17.85M | 347.74M | 8.01M | 592.00K | 24.65M | 45.87M | 10.65M | 39.89M | 36.82M | 46.16M | 75.86M | 60.83M | 61.83M | 76.38M | 41.64M |
| Diluted EPS | 0.08 | -0.79 | 0.81 | -0.16 | 0.39 | 0.23 | 0.62 | 0.67 | 0.20 | -1.33 | 0.63 | 1.02 | -0.16 | 0.29 | 0.64 | 0.86 | 0.26 | 0.10 | 2.83 | -4.86 | 0.38 | 0.44 | 0.48 | 0.18 | -1.17 | 0.36 | 7.04 | 0.18 | 0.01 | 0.53 | 1.00 | 0.25 | 0.98 | 0.93 | 1.18 | 1.98 | 1.59 | 1.67 | 2.11 | 1.20 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.46B | 1.92B | 269.04M | 350.50M | 415.40M | 465.94M | 1.91B | 1.08B | 1.21B | 960.28M | 1.01B | 866.43M | 899.25M | 1.38B | 1.45B | 1.58B | 1.79B |
| Operating Income | 234.83M | 410.90M | 501.51M | 238.93M | 166.93M | 181.27M | 156.91M | - | - | - | 155.83M | 110.07M | 110.40M | 76.75M | 168.17M | 217.05M | 341.54M |
| Net Income | 165.61M | 279.91M | 330.40M | 141.56M | 106.79M | 134.03M | 139.90M | -3.17M | 122.28M | 33.77M | 95.17M | -85.33M | 70.03M | 310.99M | 93.36M | 136.78M | 237.06M |
| Diluted EPS | 2.28 | 3.87 | 4.68 | 2.09 | 1.65 | 2.07 | 2.14 | -0.05 | 1.91 | 0.54 | 1.60 | -1.58 | 1.36 | 6.43 | 2.05 | 3.39 | 6.18 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.63B | 1.85B | 1.84B | 1.86B | 2.00B | 2.04B | 2.10B | 2.32B | 2.34B | 2.24B | 2.26B | - | 3.03B | - | 2.84B | - | 2.81B | - | 2.74B | 2.75B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 557.10M | - | - | - | 480.30M | - | 418.08M | 416.19M |
| Cash & Equivalents | 217.20M | 165.20M | 307.70M | 447.05M | 173.98M | 196.58M | 358.19M | 353.02M | 308.16M | 240.43M | 430.69M | 204.20M | 500.52M | - | 346.97M | 325.83M | 206.28M | 313.76M | 272.19M | 260.83M | 219.31M | 199.60M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.64M | - | - | - | 102.75M | - | 126.83M | 146.19M |
| Total Liabilities | - | - | 443.44M | 454.23M | 477.90M | 459.01M | 457.85M | 445.40M | 509.80M | 639.69M | 816.57M | 841.62M | 915.41M | - | 1.54B | - | 1.33B | - | 1.35B | - | 1.37B | 1.32B |
| Current Liabilities | - | - | 343.85M | 316.43M | 314.88M | 316.22M | 316.81M | 321.91M | 361.84M | 377.33M | 365.78M | 311.63M | 345.98M | - | 423.65M | - | 376.64M | - | 431.20M | - | 487.66M | 507.93M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | 125.00M | 290.07M | 398.09M | 286.12M | - | 838.91M | - | - | - | 695.08M | - | 648.71M | 552.67M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07B | - | - | - | 896.19M | - | 847.85M | 774.00M |
| Total Equity | 766.43M | 926.94M | 1.18B | 1.39B | 1.36B | 1.40B | 1.53B | 1.58B | 1.58B | 1.67B | 1.52B | 1.39B | 1.31B | - | 1.49B | - | 1.51B | - | 1.46B | - | 1.37B | 1.43B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.80M | - | - | - | 82.23M | - | 83.19M | 83.94M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 249.56M | 391.55M | 407.99M | 277.42M | 261.50M | 265.56M | 205.50M | 231.48M | 230.92M | 239.19M | 204.86M | 107.69M | 192.20M | 10.60M | 191.91M | 295.77M | 337.90M |
| Investing Cash Flow | -389.43M | -85.79M | -125.99M | -380.01M | -152.63M | -84.33M | -155.88M | -215.41M | -379.65M | -71.45M | -213.84M | 382.52M | -56.69M | -551.80M | 23.74M | -47.85M | -41.92M |
| Financing Cash Flow | 86.17M | -161.84M | -140.19M | -168.02M | -82.56M | -19.14M | -48.61M | -69.09M | 85.84M | 37.20M | -137.53M | -256.11M | 676.47M | -424.48M | -288.51M | -301.80M | -316.02M |
| Capital Expenditure | - | - | - | - | - | -79.36M | -88.71M | -51.45M | -42.51M | -46.62M | -57.57M | -39.60M | -39.88M | -31.05M | -26.01M | -48.89M | -50.33M |
| Free Cash Flow | - | - | - | - | - | 186.21M | 116.80M | 180.03M | 188.41M | 192.57M | 147.28M | 68.09M | 152.32M | -20.45M | 165.90M | 246.88M | 287.57M |
| Share Buybacks | 33.68M | 41.68M | 132.94M | 158.09M | 53.89M | 0 | 25.92M | 32.63M | 48.51M | 137.03M | 252.85M | 136.89M | 100.00M | 120.00M | 123.13M | 261.97M | 213.12M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 16.1% | 21.5% | 186.4% | 68.2% | 40.2% | 38.9% | 8.2% | - | - | - | 15.4% | 12.7% | 12.3% | 5.6% | 11.6% | 13.7% | 19.1% |
| Net Margin % | 11.3% | 14.6% | 122.8% | 40.4% | 25.7% | 28.8% | 7.3% | -0.3% | 10.1% | 3.5% | 9.4% | -9.8% | 7.8% | 22.5% | 6.4% | 8.6% | 13.3% |
| ROE % | 17.9% | 23.7% | 23.8% | 10.4% | 7.6% | 8.7% | 8.8% | -0.2% | 7.3% | 2.2% | 6.8% | -6.5% | - | 20.9% | 6.4% | 10.0% | 16.5% |
| ROCE % | - | 32.0% | 32.7% | 15.6% | 10.8% | 10.8% | 9.1% | - | - | - | 8.1% | 5.8% | - | 2.9% | 7.1% | 9.6% | 15.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 15.37% | 5.23M | $690.87M |
| 2 | FMR, LLC | 7.80% | 2.65M | $350.65M |
| 3 | Vanguard Portfolio Management LLC | 7.12% | 2.42M | $319.92M |
| 4 | Ariel Investments, LLC | 5.68% | 1.93M | $255.14M |
| 5 | Dimensional Fund Advisors LP | 5.21% | 1.77M | $234.31M |
| 6 | Vanguard Capital Management LLC | 4.38% | 1.49M | $196.91M |
| 7 | State Street Corporation | 3.97% | 1.35M | $178.26M |
| 8 | Capital World Investors | 3.02% | 1.03M | $135.99M |
| 9 | Geode Capital Management, LLC | 2.51% | 854.01K | $112.82M |
| 10 | Wellington Management Group, LLP | 2.40% | 816.30K | $107.84M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CVSA
$CVSA stock is down 11% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPOS1KcDNsdXN4MFFJWFFXZ05EeUthWFdRQy1JX3VxaHl1dE5nYU5fSTRKT0VmZEZqWVBpcTJ2SjVwbU1sOGh3VXJYNzJyQlk0clNMYWYtTHg0TlFVcHZ5d1cxRXpyTXFyT21VZFBHS0h5WkI3djF2SHFjOTZXTzdueFBHMmFqMW9PR2c1OV…
Covista Inc (CVSA) Stock Down 12.3% but Still Overvalued -- GF Score: 90/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNWlhtMGFib2tIeDVtblJlcWxqRlBPWE5WLUFDNVJnSXFwYmI0UnZpbkJxbHV3cnBVNVBjb3B3ZWRnZEVyVnF5Qm1EblF1N0F6VFIzZEowbXZzVkJScVJrclEyYXFObFRJRnZsbDh4RlVQc0w5UjFhSHoxSk1yOWdzWlhKNjFMWDVOY1NZRy…
Insider Sale: Chairman & CEO of $CVSA Sells 5,291 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPdVd0X1N1MW1YSUFzQzhvN09ibm1GQWFHaXZXOE1mTVlBTzNyQ3NFX1ZtdnBrZlRDYzFiU2ppRVVDZ3lGcTExQnkwRVNrQk0yTXVsZm9NRWs1UzljcGF6NGxRQ2h6aXJ4QnQtUFB6QTRFSjZUc05oVlpkbmRiSk5GS2k0OUZ2X2pLV25RTG…
Covista chairman & CEO Stephen Beard sells $702,401 in stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNWHB3N0V5Y3kyRXhxVTBFYTRkTjZSQS1jMGJYalk1VDdwQzh6MzZZbUdEUXIzbWlnM2g5T2NhTHM4dW5vaGl3RU0tR0JpckZCQ0RjelcwNlluczlnRXBPRHhtVC14aUFOcUR1cUN5bmVHSnVLZGQtSUppUVF1MXRrVUZOTTN0MjZodExuZG…
$10M in grants and 50,000 volunteer hours aimed at easing the healthcare worker shortage - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPTkVyWGEzYmpqT05zYkZkTU5SNTJWd3JkMDV6VDFSbVk5bUJrSzJSRjVxM1I1NmtjVkR1aGYwQzZlZFVLS250TjVKWGJJN1VnQU9ORnNxVF9pb0h4Qy1hUmRVTUFUeldwZEdNcTFUUktKWUZrZWg3eUZVWVRxNFlBMmpNVHNlV1IxcUoxVU…
How Analyst Concerns on Capital Intensity and Returns Could Reframe Covista’s (CVSA) Investment Narrative - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPMlBxWGJWQkJ0cjNpandFenEzOE16cTBOdU5fR1gwN1Q5RHNndkVOYUlndGtvYmJIUkU1ck5QMVhsdDlhdnAxeHRnMC10QkQwRUhDZDBTYmh6TnIxaUZMZ3hqSGprMUN5RGZ0bldfMW9JN0RkX0dJOFdxSWhxbVhvWDg2R2JRdlRXX0N2b2…
CVSA — Frequently Asked Questions
What is the current share price of Covista Inc. (CVSA)?
As of 2026-07-15 16:51 PDT, Covista Inc. (CVSA) trades at $115.82 on NYSE. Its 52-week range is $89.36 to $154.45.
What is the market capitalisation of CVSA?
Covista Inc. (CVSA) has a market capitalisation of $3.94B on NYSE.
What is the P/E ratio of CVSA?
CVSA trades at a trailing price-to-earnings (P/E) ratio of 16.98. The industry average P/E is 20.61. Its price-to-book (P/B) ratio is 3.30.
What is the return on equity (ROE) of CVSA?
CVSA has a return on equity (ROE) of 17.85%. Its return on capital employed (ROCE) is 15.22%.
Is CVSA a good stock to buy?
This page provides a data-driven analysis of Covista Inc. (CVSA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.